Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05472688 · ClinicalTrials.gov registry record
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
A clinical trial of Dysbiosis, sponsored by Persephone Biosciences.
- Active
- Registry status
- 430
- Enrollment target
- 1
- Study location
NCT05472688 is a study of Dysbiosis that is active but no longer recruiting, run by Persephone Biosciences. The registered enrollment target is 430 participants, above the 81-participant average among 13 other Dysbiosis trials with a reported enrollment target (431% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05472688, a study of Dysbiosis, is active but no longer recruiting, sponsored by Persephone Biosciences.
- ACTIVE NOT RECRUITING
- Registry status
- 430 participants
- Enrollment target
- 1
- Study location
Study Summary
My Baby Biome is an observational study that will use 600 infant stool samples to determine the biomarkers associated with a healthy infant gut. Biomarkers identified in this study will be used to develop precision probiotics and LBPs for improving infant gut health outcomes to the benefit of all infants. Parents will be asked to submit follow-up questionnaires regarding infant immune health to improve insights obtained from the data.
Conditions Studied
Study Locations (1)
California
- Persephone Biosciences, Inc. - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05472688
The ClinicalTrials.gov registry entry for NCT05472688 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 13 other Dysbiosis trials with a reported enrollment target (431% higher). The listed sponsor is Persephone Biosciences, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dysbiosis appearing as the primary indexed condition, and to 0 interventions.
NCT05472688 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05472688 about?
NCT05472688 is a clinical study titled "My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)". My Baby Biome is an observational study that will use 600 infant stool samples to determine the biomarkers associated with a healthy infant gut. Biomarkers identified in this study will be used to develop precision probiotics and LBPs for improving infant gut health outcomes to the benefit of all in...
What is the current status of trial NCT05472688?
This trial is currently active not recruiting. The enrollment target is 430 participants. The study started on 2022-07-14. Estimated completion is 2029-12-31.
What conditions does trial NCT05472688 study?
This clinical trial studies the following conditions: Dysbiosis.
Who is sponsoring clinical trial NCT05472688?
This trial is sponsored by Persephone Biosciences, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05472688 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysbiosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Peanut Butter on Gut and Metabolic Health
RECRUITING · NA
-
Personalized GI Motility Responses to Diet
RECRUITING · NA
-
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
RECRUITING · NA
-
A Study of Healthy Microbiome, Healthy Mind
RECRUITING · NA
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Effect of Watermelon on Gut and Cardiometabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.